Seeds and markers for use in imaging
View Patent ↗A contrast marker having a casing and a novel MRI contrast agent comprising metal complexes disposed around, within, or abuting the casing is provided. Such contrast markers may be placed in a strand, with or without a therapy seed, to produce a seeded strand useful for imaging and in connection with brachytherapy.
1. A contrast marker, the marker comprising: a casing; and
a contrast agent comprising at least one transition metal complex solution disposed within the casing, wherein the transition metal complex includes [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95).
2. The contrast marker of claim 1 , further comprising a carrier substrate positioned within the casing.
3. The contrast marker of claim 1 , further comprising a radioactive therapeutic agent disposed within the casing.
4. A strand comprising: at least one contrast marker of claim 1 positioned with a strand.
5. The strand of claim 4 further comprising at least one therapy seed wherein the contrast marker and the therapy seed are positioned within the strand.
6. The strand of claim 4 further comprising at least one spacer element.
7. A strand comprising at least one contrast marker of claim 1 and a radioactive agent selected from the group consisting of palladium-103, iodine-125, and cesium-131 wherein said marker and said therapy agent are positioned within a strand.
8. A strand comprising [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95), and a therapy seed positioned with a strand.
9. A method of making a strand comprising:
providing a polymer strand having a strand bore;
positioning at least one therapy seed comprising a radioactive agent disposed within a carrier substrate in said strand bore; and
positioning at least one contrast marker in said strand bore in a spaced relationship to said therapy seed, wherein the contrast marker includes [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95).
10. The method of claim 9 further comprising positioning a spacer element within the strand bore.
11. A contrast agent comprising [(CoCl 2 ) n(C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95).
12. A therapy seed comprising a radioactive agent wherein said seed further comprises a contrast marker disposed within said seed, wherein the contrast marker includes [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95).
13. A therapy seed comprising a radioactive agent wherein said seed further comprises the contrast agent of claim 11 .
14. A therapy seed of claim 13 wherein said therapy seed is coated with the contrast agent.
15. A contrast marker, the marker comprising: an casing; and
a contrast agent comprising [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95), wherein the agent is coated around the casing.
16. A method of making a contrast agent useful in magnetic resonance imaging comprising the steps of:
determining the T1 relaxation time of a first contrast agent comprising [(CoCl 2 ) n (C 2 H 5 NO 2 ) 1-n ] (where n=0.5-0.95); and
providing a second contrast agent wherein the concentration level of the second contrast agent is adjusted so as to produce substantially similar T1 relaxation times for MR imaging to the first contrast agent.
17. The method of claim 16 , wherein the second contrast agent is a contrast agent comprising gadolinium chelated with a multidentate ligand.